Dark Mode Light Mode

Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet

The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.

Previous Post

Altcoin rally led by ETH, BNB, AVAX, PENGU likely if Bitcoin range break occurs

Next Post

Bumrah to miss the fifth Test against England

Advertisement
You have not selected any currencies to display